Please assess the completion status of the following clinical trial:

Trial Title: Palliation of Dyspnea With Mouth Piece Ventilation in AECOPD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* a previous diagnosis of COPD~* hospitalized due to acute exacerbation of COPD~* at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4)~* no acute hypoventilation (pH ≥ 7.35 and PCO2 ≤ 6.0 kPa)~* able to understand the study and to give informed consent~Exclusion Criteria:~* unable to participate and use MPV due to e.g. delirium or lack of co-operation~* acute hypoventilation (pH \< 7.35 or PCO2 \> 6.0 kPa)~* acute need for ventilatory support~* the cause of the dyspnea can be successfully treated~* unable to give informed consent~* a previous chronic hypoxemic or hypercapnic respiratory insufficiency that has been treated on a long-term basis also at home

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MPV-arm (Type: EXPERIMENTAL): Subjects use mouth piece ventilation (MPV) according to their will for 24 hours to alleviate dyspnea.

Based on this trial design, predict the completion outcome and termination type (if applicable).